CLUSTER filed Jun 15, 2026 at 18:50 ET
Two insiders at Oruka Therapeutics, General Counsel Paul Quinlan and Director Carl Dambkowski, sold a combined $933K in open-market transactions over four days. While the insider cluster is selling, the total value is only ~0.02% of the company's $4.2B market cap, making the signal economically trivial. The cross-filing actuarial verdicts strongly amplify the cluster-earnings-context and cluster-insider-trades pair, but neither earnings nor other material cross-filings are present in the actual context provided, so the amplifiers fire without a substantive base event.